
Sanofi names new board member
pharmafile | November 20, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Sanofi, bonnie bassler
Sanofi has appointed Professor Bonnie Bassler as an independent member to sit among its board of directors.
Bassler has more than 20 years of experience in molecular biology and leads one of the most prestigious academic biology departments in the world.
She is a Howard Hughes Medical Institute investigator, the Squibb Professor in molecular biology, and the chair of the department of molecular biology at Princeton University in the US.
“Professor Bassler’s scientific expertise in Molecular Biology and her great leadership skills makes her an outstanding addition to our board,” says Serge Weinberg, chairman of the board and chief executive at Sanofi.
Appointed by Barack Obama in 2011, Professor Bassler serves as a member of the United States National Science Board which oversees the National Science Foundation.
Bassler says: “It is a great honour for me to join Sanofi’s board of directors. Sanofi is one of the leading international pharmaceutical companies in the world and I look forward to working closely with members of the board and the company to support Sanofi’s mission to develop and introduce innovative therapies.”
Related Content

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria
Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee …

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition
The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) …

Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline
Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology …






